EUVIMEDEUVIMED entdecken
Crossref

Jiedu Tongluo Tiaogan Formula Modulates Glycolipid Metabolism in Type 2 Diabetes via Pyroptosis: Network Pharmacology and In Vivo Analysis

Su Jing, Cui Zhenhai, Han Xiao, Li Chunhan, Wang Wanlin, Song Xuting, Yu Han, Zhuang Xiaoyu, Jin Meiying iD

Biomedical Chromatography · 2025

DOI: 10.1002/bmc.70077 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomedical Chromatography, 2025. Verfasst von Su Jing und 8 weiteren Autor:innen. Beteiligte Einrichtung: Changchun University of Chinese Medicine, Changchun, China. Hauptthemen laut MEDLINE: Pyroptosis, Diabetes Mellitus, Type 2, Drugs, Chinese Herbal, Glycolipids. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 70 Literaturangaben. Gefördert von: Natural Science Foundation of Jilin Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Type 2 diabetes mellitus (T2DM) is characterized by pancreatic β‐cell dysfunction and insulin resistance, with pyroptosis emerging as a key contributor to β‐cell loss. Jiedu Tongluo Tiaogan Formula (JTTF), a traditional Chinese medicine (TCM), has shown clinical efficacy in T2DM management, but its mechanism linking pyroptosis remains unexplored. This study integrates UPLC‐MS/MS, network pharmacology, and in vivo experiments to elucidate JTTF's anti‐diabetic mechanisms. UPLC‐MS/MS identified 441 compounds in JTTF, predominantly alkaloids, flavonoids, phenols, and terpenoids. Network pharmacology revealed JTTF's multi‐target effects on T2DM‐associated pyroptosis, particularly via the NLRP3/Caspase‐1/GSDMD pathway. In diabetic mice, JTTF dose‐dependently reduced fasting blood glucose, insulin resistance, and dyslipidemia, while restoring pancreatic β‐cell morphology. Mechanistically, JTTF suppressed NLRP3 inflammasome activation, downregulated Caspase‐1 and GSDMD expression, and attenuated IL‐1β/IL‐18 release. Notably, this study provides the first evidence of JTTF's anti‐pyroptotic effects in T2DM, highlighting its unique ability to modulate glycolipid metabolism and inflammatory cell death concurrently. These findings underscore JTTF's translational promise for preserving β‐cell function and suggest future exploration of non‐classical pyroptosis pathways. Our work bridges traditional medicine and molecular pharmacology, paving the way for clinical trials and integrative T2DM therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PyroptosisDiabetes Mellitus, Type 2Drugs, Chinese HerbalGlycolipidsAnimalsMiceMaleMice, Inbred C57BLNetwork PharmacologyTandem Mass SpectrometryDiabetes Mellitus, ExperimentalInflammasomesNLR Family, Pyrin Domain-Containing 3 Protein

Stichwörter der Autor:innen

JTTFNLRP3/Caspase‐1/GSDMD pathwaynetwork pharmacologypyroptosistype 2 diabetes mellitus

Substanzen

Drugs, Chinese HerbalGlycolipidsInflammasomesNLR Family, Pyrin Domain-Containing 3 Protein

Autor:innen und Institutionen

  • Changchun University of Chinese Medicine, Changchun, China.
  • Jilin Hospital of Integrated Traditional Chinese and Western Medicine, Jilin, China.

ORCID-Profile: Jin Meiying

Förderung

  • Natural Science Foundation of Jilin Province

Zitieren

APA

Jing, S., Zhenhai, C., Xiao, H., Chunhan, L., Wanlin, W., Xuting, S., Han, Y., Xiaoyu, Z., & Meiying, J. (2025). Jiedu Tongluo Tiaogan Formula Modulates Glycolipid Metabolism in Type 2 Diabetes via Pyroptosis: Network Pharmacology and In Vivo Analysis. Biomedical Chromatography. https://doi.org/10.1002/bmc.70077

Vancouver

Jing S, Zhenhai C, Xiao H, Chunhan L, Wanlin W, Xuting S, et al. Jiedu Tongluo Tiaogan Formula Modulates Glycolipid Metabolism in Type 2 Diabetes via Pyroptosis: Network Pharmacology and In Vivo Analysis. Biomedical Chromatography. 2025. doi:10.1002/bmc.70077

BibTeX
@article{Jing2025,
  author = {Jing, Su and Zhenhai, Cui and Xiao, Han and Chunhan, Li and Wanlin, Wang and Xuting, Song and Han, Yu and Xiaoyu, Zhuang and Meiying, Jin},
  title = {Jiedu Tongluo Tiaogan Formula Modulates Glycolipid Metabolism in Type 2 Diabetes via Pyroptosis: Network Pharmacology and In Vivo Analysis},
  journal = {Biomedical Chromatography},
  year = {2025},
  doi = {10.1002/bmc.70077}
}
Kostenlos starten →